Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Norepinephrine bitartrate monohydrate
Cat. No.:
OB0225LY-0276
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Norepinephrine bitartrate monohydrate is an important neurotransmitter involved in the regulation of many physiological functions.
Synonym:
Levophed; Noradrenaline bitartrate monohydrate; 108341-18-0; L-Noradrenaline bitartrate monohydrate; 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-,(2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate; 4-[(1R)-2-Amino-1-hydroxyethyl]benzene-1,2-diol; (2R,3R)-2,3-dihydroxybutanedioic acid; hydrate; 1,2-Benzenediol, 4-((1R)-2-amino-1-hydroxyethyl)-, (2R,3R)-2,3-dihydroxybutanedioate hydrate
CAS No.:
108341-18-0
Compound CID:
3047796
Formula:
C8H11NO3·C4H6O6·H2O
Formula Weight:
337.28
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Norepinephrine bitartrate monohydrate can be used in neuroscience research, especially in the study of neurotransmitter action and signaling where it is important.
Library Information
Targets:
Adrenergic receptor
Receptors:
β1-Adrenergic receptor
Pathways:
GPCR/G protein; Metabolism; Neuronal signaling; Autophagy
Plate Number:
AOCL-4
Plate Location:
e5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 148.24 mM
Water Max Solubility:
31.9 mg/mL; 100 mM
